Seeing Is Believing
XGN is currently covered by 4 analysts with an average price target of $7.82. This is a potential upside of $6.42 (458.57%) from yesterday's end of day stock price of $1.4.
Exagen's activity chart (see below) currently has 16 price targets and 19 ratings on display. The stock rating distribution of XGN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 20.67 days.
Highest price target for XGN is $6, Lowest price target is $6, average price target is $7.82.
Most recent stock forecast was given by ROSS OSBORN from CANTOR FITZGERALD on 26-Sep-2023. First documented stock forecast 01-Jun-2020.
Currently out of the existing stock ratings of XGN, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
6
$4.51 (302.68%)
6
6 months 28 days ago
0/4 (0%)
$3.62 (152.10%)
Buy
5
$3.51 (235.57%)
7
1 years 1 months 1 days ago
0/3 (0%)
$2.76 (123.21%)
Buy
7
$5.51 (369.80%)
17
1 years 5 months 8 days ago
3/6 (50%)
$4.01 (134.11%)
124
Buy
17
$15.51 (1040.94%)
20
1 years 11 months 10 days ago
0/4 (0%)
$12.17 (251.97%)
Buy
16
$14.51 (973.83%)
2 years 1 months ago
0/2 (0%)
$7.25 (82.86%)
What is XGN (Exagen) average time for price targets to be met?
Which analyst has the current highest performing score on XGN (Exagen) with a proven track record?
Which analyst has the current lower performing score on XGN (Exagen) with a proven track record?
Which analyst has the most public recommendations on XGN (Exagen)?
Which analyst is the currently most bullish on XGN (Exagen)?
Which analyst is the currently most reserved on XGN (Exagen)?